Moreover, SII and NT-proBNP represented independent determinants of clinical prognosis in acute STEMI patients when considering a composite endpoint (including all-cause mortality, re-hospitalization, nonfatal myocardial infarction, acute heart failure, and non-fatal stroke), and they were positively correlated [41]. The gene discussed is NPPB; the disease is stroke disorder.